Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study.
Int J Environ Res Public Health. 2021 Apr 27;18(9):4624. doi: 10.3390/ijerph18094624.
Int J Environ Res Public Health. 2021.
PMID: 33925369
Free PMC article.
Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid.
Gao X, Wu L, Tsai RYL, Ma J, Liu X, Chow DS, Liang D, Xie H.
Gao X, et al.
Pharmaceutics. 2021 Apr 17;13(4):574. doi: 10.3390/pharmaceutics13040574.
Pharmaceutics. 2021.
PMID: 33920640
Free PMC article.
Item in Clipboard
A Qualitative Analysis to Understand Perception about Medication-Related Problems among Older Minority Adults in a Historically Black Community.
Poon IO, Skelton F, Bean LR, Guinn D, Jemerson T, Mbue ND, Charles CV, Ndefo UA.
Poon IO, et al.
Pharmacy (Basel). 2022 Jan 7;10(1):14. doi: 10.3390/pharmacy10010014.
Pharmacy (Basel). 2022.
PMID: 35076623
Free PMC article.
Item in Clipboard
Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies.
Wang Y, Xie H, Alugubelli YR, Ma Y, Xu S, Ma J, Liu WR, Liang D.
Wang Y, et al.
Pharmaceuticals (Basel). 2022 May 27;15(6):676. doi: 10.3390/ph15060676.
Pharmaceuticals (Basel). 2022.
PMID: 35745595
Free PMC article.
Item in Clipboard
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.
Ekpenyong O, Cooper C, Ma J, Guy NC, Payan AN, Ban F, Cherkasov A, Cox MB, Liang D, Xie H.
Ekpenyong O, et al.
Pharmaceuticals (Basel). 2020 Nov 13;13(11):386. doi: 10.3390/ph13110386.
Pharmaceuticals (Basel). 2020.
PMID: 33202977
Free PMC article.
Item in Clipboard
Cite
Cite